Speakers: Steve Mister, Esq., President & CEO, CRN; Daniel Fabricant, Ph.D., Director, Division of Dietary Supplement Programs, Food and Drug Administration (FDA); Katie Bond, Associate in the Washington, D.C. office of Kelley Drye & Warren LLP; Edward Wyszumiala, General Manager, NSF International; Justin J. Prochnow, Shareholder, Greenberg Traurig, LLP
INSIDER Premium Series
Available On-Demand: November 21, 2012 - February 14, 2013
CRN Member Price: $149*
*Discount subject to verification. Registrants that use the CRN member discount and are not members will be charged the additional $50 towards full registration.
Non-CRN Member Price: $199
• Weight loss • Sexual enhancement • Bodybuilding • Diabetes • Pain
FDA has identified these five categories as the most likely to contain tainted products. Trial lawyers have identified them as targets. How do you make and sell these products and avoid having your products labeled "buyer beware"? If you operate in one or more of these categories, how do you do so responsibly? The latest CRN/VIRGO industry Webinar, “Doing Business in High-Risk Categories," tells you how.
If you make and sell products in these categories then this Webinar is for you.
Hear from a distinguished panel on
• Why FDA characterizes these categories as high-risk • Managing the supply chain—avoiding tainted products • Advertising—walking a fine line between what’s allowed and what’s not • Class action lawsuits—preparing and protecting your company
Steve Mister, Esq. President & CEO, CRN
Mr. Mister has been President and CEO of CRN since 2005. Under his leadership, CRN has experienced a refined strategic focus, increased membership, and launched new initiatives to enhance consumer confidence in the supplement industry. Among CRN’s recent achievements are the creation of a highly successful consumer campaign Life…supplemented and a program with the National Advertising Division of the Council of Better Business Bureaus to review supplement advertising. In addition to his role as President and CEO of CRN, he is also the President of the CRN Foundation. Prior to joining CRN, Mr. Mister served in several legal and legislative roles for over a decade at the Consumer Healthcare Products Association (CHPA), most recently as Vice President and Associate General Counsel. Mr. Mister also worked as an attorney in the Washington, D.C., law firm of Wiley, Rein & Fielding in general litigation, government ethics, and federal election law practice groups, and had a stint on Capitol Hill as a media relations assistant for former U.S. Senator Charles McC. Mathias, Jr. Mr. Mister holds a law degree from the College of William and Mary, an M.A. in Political Communication from the University of Maryland and a B.S. from Towson University.
Daniel Fabricant, Ph.D., Director, Division of Dietary Supplement Programs, Food and Drug Administration (FDA)
Daniel Fabricant was named Division Director for Dietary Supplement Programs at the Food and Drug Administration (FDA) in February 2011. Dr. Fabricant directs and coordinates policy, budget, personnel, regulatory priorities and administrative activities within the division. He advises on policy, and management issues and decisions, and provides expert advice and assistance to the Office of Nutrition, Labeling, and Dietary Supplements Director, CFSAN management and other key FDA officials on dietary supplement programs, new dietary ingredient safety assessments, good manufacturing practices, adverse event monitoring and related activities pertaining to dietary supplements. Dr. Fabricant is responsible for the full implementation of DSHEA through the interpretation and enforcement of dietary supplement requirements that ensure the safety and truthful labeling of dietary supplements, support legislative compliance, enforcement and public affairs initiatives.
Katie Bond Associate in the Washington, D.C. office of Kelley Drye & Warren LLP
Katie Bond practices food and drug law and advertising law, with a specific focus on health-related advertising. Ms. Bond has significant experience representing clients in the functional food, dietary supplement and sports/fitness industries.
She regularly reviews clients’ labeling and marketing material for compliance with Federal Trade Commission (FTC), Food and Drug Administration (FDA), and other applicable requirements. She has participated in Lanham Act and other litigation over health-related labeling and advertising and has helped represent clients before federal and state regulators and the self-regulatory bodies of the National Advertising Review Council.
Prior to attending law school, Ms. Bond served as a development associate with the Asian American Justice Center, an organization working to advance human and civil rights of Asian Americans through advocacy and public education.
Ms. Bond writes frequently about consumer protection law issues, including those that affect the dietary supplement industry. Recent publications include “Foreign Territory: Dietary Supplement Clinical Trials Conducted Abroad,” published by Nutritional Outlook, and “New Standards, Heightened Enforcement, and Increased Litigation: Managing the New Legal Risks Facing Food and Dietary Supplement Companies,” a book chapter in Recent Developments in Food and Drug Law, Aspatore Books, 2012. Ms. Bond is a contributor to the Ad Law Access blog (www.adlawaccess.com), which provides updates on advertising law trends, issues and developments. Contact her at firstname.lastname@example.org.
Edward Wyszumiala General Manager, NSF International
Edward Wyszumiala is general manager of NSF International’s Dietary Supplement Certification Programs. He is responsible for overseeing the NSF Dietary Supplement and Athletic Banned Substances (Certified for Sport®) Programs. Wyszumiala has more than eight years of experience in the dietary supplement, sports nutrition, and nutraceuticals industries with expertise in product certification, Good Manufacturing Practices (GMP), athletic banned substances screening, and international dietary supplement regulations. He is a member of several industry associations, including the American Herbal Products Association and the United Natural Products Alliance. Prior to joining NSF, Wyszumiala was COO for Graminex. He is a graduate of Ohio State University.
Justin J. Prochnow Shareholder, Greenberg Traurig, LLP
Justin J. Prochnow is a former prosecutor that focuses his practice on assisting companies with regulatory, business and legal issues. Justin works with dietary supplement, sports nutrition, beverage, conventional food, cosmetic, medical device and OTC drug companies to ensure regulatory compliance with statutes and regulations enforced by the Food and Drug Administration, the Federal Trade Commission and other regulatory agencies. Justin prepares a wide range of business documents for industry members, including manufacturing, supply and distribution agreements. Justin also defends companies from both governmental agencies and private litigants with claims ranging from breach of contract and false advertising to class actions for Lanham Act and California state law claims.